Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent ®) in Open-Angle Glaucoma.

CONCLUSIONS: This prospective interventional study demonstrates persistent 5-year reductions in IOP and freedom from medications, together with favorable safety, following implantation of 2 first-generation trabecular micro-bypass stents in eyes with OAG on 1 preoperative medication. PMID: 32715828 [PubMed - as supplied by publisher]
Source: Current Eye Research - Category: Opthalmology Authors: Tags: Curr Eye Res Source Type: research
More News: Eyes | Glaucoma | Opthalmology | Study